Transdermal fentanyl in HSCT patients: An open trial using transdermal fentanyl for the treatment of oral mucositis pain

Bone Marrow Transplantation

Volumn 33, Issue 12, 2004, Pages 1247-1251

  Demarosi, Federica ^a   Lodi, G ^a   Soligo, D ^a   Sardella, A ^a   Della Volpe, A ^a   Carrassi, A ^a   Lambertenghi Deliliers, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Fentanyl; Mucositis; Pain; Stem cell transplantation

Indexed keywords

BUSULFAN; CARMUSTINE; CHLORHEXIDINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FENTANYL; MELPHALAN; MORPHINE; NYSTATIN; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTHWASH; MUCOSA INFLAMMATION; NAUSEA; OPEN STUDY; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SUSPENSION; TRANSDERMAL PATCH; VISUAL ANALOG SCALE; VOMITING; WHOLE BODY RADIATION;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; FEMALE; FENTANYL; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; PAIN; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STOMATITIS; TREATMENT OUTCOME;

EID: 3242692512     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704515     Document Type: Article

References (14)

1. Eisen D, Essell J, Broun ER. Oral cavity complications of bone marrow transplantation. Semin Cutan Med Surg 1997; 16: 265-272.
2. Pillitteri LC, Clark RE. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplant 1998; 22: 495-498.
3. Jeal W, Benfield P. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control. Drugs 1997; 53: 109-138.
4. Donner B, Zenz M, Tryba M, Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with.cancer pain. Pain 1996; 64: 527-534.
5. Gourlay GK. Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2001; 2: 165-172.
6. Grond S, Zech D, Lehmann KA et al. Transdermal fentanyl in the long-term treatment of cancer pain: a prospective study of 50 patients with advanced cancer of the gastro-intestinal tract or the head and neck region. Pain 1997; 69: 191-198.
7. Donner B, Zenz M, Strumpf M, Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage 1998; 15: 168-175.
8. Sloan PA, Moulin DE, Hays H. A clinical evaluation of transdermal therapeutic system fentanyl for the treatment of cancer pain. J Pain Symptom Manage 1998; 16: 102-111.
9. Allan L, Hays H, Jensen NH et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001; 322: 1154-1158.
10. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC. Scoring oral mucositis. Oral Oncol 1998; 34: 63-71.
11. Scott J, Huskisson EC. Graphic representation of pain. Pain 1976; 2: 175-184.
12. Demarosi F, Soligo D, Lodi G et al. Prospective evaluation of transdermal fentanyl in symptomatic treatment of oral mucositis in patients undergoing bone marrow transplantation. Bone Marrow Transplant 2003; 31 (Suppl.): 220 (abstr. 752).
13. Strupp C, Sudhoff T, Germing U et al. Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support. Oncol Rep 2000; 7: 659-661.
14. Chapman CR, Donaldson GW, Jacobson RC, Hautman B. Differences among patients in opioid self-administration during bone marrow transplantation. Pain 1997; 71: 213-223.